Senior Director, Translational Medicine- CNS

Leads all activities related to Pharmacology and Translational Sciences essential to the growth of Otsuka’s discovery and early phase pipeline. Responsible for identifying and utilizing emerging Translational and Pharmacology studies and tools, new technologies and scientific capabilities for the growth of Otsuka’s early phase capabilities. Lead EDTS members and interactions with discovery teams, Business Development (BD) and McQuade Center for Research and Development (MSRD) or academic centers to evaluate, support research related to internal and external assets. Oversee pharmacology and translational activities related to late-stage compounds and oversee development of pharmacology sections of IND, NDA and CTD submission. The Senior Director, EDTS in alignment with functional head VP, collaborates with other senior leaders to identify, introduce, and implement translational tools or studies for discovery and early phase programs and establish strategic plans and objectives.

Leads all activities related to Pharmacology and Translational Sciences essential to the growth of Otsuka’s discovery and early phase pipeline. Responsible for identifying and utilizing emerging Translational and Pharmacology studies and tools, new technologies and scientific capabilities for the growth of Otsuka’s early phase capabilities. Lead EDTS members and interactions with discovery teams, Business Development (BD) and McQuade Center for Research and Development (MSRD) or academic centers to evaluate, support research related to internal and external assets. Oversee pharmacology and translational activities related to late-stage compounds and oversee development of pharmacology sections of IND, NDA and CTD submission. The Senior Director, EDTS in alignment with functional head VP, collaborates with other senior leaders to identify, introduce, and implement translational tools or studies for discovery and early phase programs and establish strategic plans and objectives.

• Interact with internal and external groups to evaluate new compounds, molecular and biological targets as well as new formulation technologies.
• Partner with internal and external research organizations to expand and facilitate development of early phase and discovery phase compounds.
• Provide expert advice to internal and external stakeholders and interact with subject matter experts for early development and go/no go decisions related to the discovery as well as early phase assets.
• Provide expert advice to internal and external discovery teams as well as academic and early investment partners on early development, lead optimization and go/no go decisions.
• Represent EDTS in cross functional as well as internal/external collaborations (BD, MSRD, etc.) on activities related to early phase target and asset identification.
• Lead discovery and translational efforts related to target identification, lead identification through IND …